DOI: http://dx.doi.org/10.18203/2349-2902.isj20203796

Stuttering priapism post C-spine schwannoma excision: case report

Ngwobia Peter Agwu, Ali Lasseini

Abstract


Priapism is prolonged penile erection that persists beyond or is unrelated to sexual stimulation and this is associated with significant psychological, socioeconomic and physical morbidity. It is a urologic emergency as delayed intervention may result in penile fibrosis and consequent erectile dysfunction. The aim of this paper is to present our experience in the management of the rare occurrence of stuttering priapism in a 32 years old man following surgical excision of cervical schwannoma during the early postoperative period and review relevant literature on management of this urologic entity. Stuttering priapism may complicate cervical spine tumor excision but may demonstrate complete patient recovery.

 


Keywords


Abnormal erectile physiology, Cervical spine trauma, Prevention, Pharmacologic therapy

Full Text:

PDF

References


Levey HR, Segel RL, Bivalacqua TJ. Management of priapism: an update for clinicians. Adv Urol. 2004;6:230-44.

Kato GJ. Priapism in Sickle cell disease: a haematologist’s perspective. J Sex Med. 2012;9:70-8.

Medina CA. Clitoral priapism: A rare condition presenting as a case of vulvar pain. Obstet Gynecol. 2002;100:1089-91.

Driel VMF. Physiology of penile erection- a brief history of scientific understanding up till eighties of the 20th century. Sex Med. 2015;3:349-57.

Prieto D. Physiological regulation of penile arteries and veins. Int J Impotence Res. 2008;20:17-29.

Garthwaite J. Concepts of neural nitric oxide-mediated transmission. European J Neurosci. 2008;27:2783-802.

Phatarpekar PV, Wen J, Xia Y. Role of Adenosine signalling in Penile Erectile Disorders. J Sex Med. 2010;7:3553-64.

King SH, Mayorov AV, Srinivasar BP, Hruby, VJ, Vanderah TW, Wessels H. Melanocortin Receptors, Melanotropic Peptides and Penile Erection. Curr Top Med Chem. 2007;7:1098-106.

D’Emmanele DVBR, Mitidieri E, Fusco F, D’Aiuto E, Griew P. Endogenous Urotensin II selectively Modulates Erectile Function through eNos. PLOS ONE. 2012;7:e31019.

Basset J, Rajfar J. Diagnostic and Therapeutic Options for the management if ischaemic and non- ischaemic priapism. Reviews Urology. 2010;12:56-63.

Burnett AL, Bivalacqua TJ. Glucose-6-Phosphate Dehydrogenase Deficiency: An Etiology for Idiopathic Priapism? J Sex Med. 2008;5:237-40.

Prabhakaran K, Jacobs BL, Smaldone MC, Franks ME. Stuttering priapism associated with hereditary spherocytosis. Can J Urol. 2007;14:3702-4.

Baytunca MB, Kose S, Ozbaran B, Erermis S. Risperidone, quetiapine and chlorpromazine may have induced priapism in an adolescent. Pediatr Int. 2016;58(1):61-3.

Todd NV. Priapism in acute spinal cord injury. Spinal Cord. 2011;4:1033-5.

Gordon SA, Stage KH, Tansey KEC, Lotan Y. Conservative management of priapism in acute spinal cord injury. Urology. 2005;65:1195-7.

Kim DW, Chae JY, Kim JW, Yoon CY, Oh MM, Kim JJ, et al. Stuttering Priapism in a patient with Neurosyphilis. World J Men Health. 2013;31:76-8.

Akinbani A, Uche E, Dosunmu A. Priapism in sickle cell disease: Emergency room intervention. Ann Trop Path. 2017;8:5-10.

Nerli RB, Magduma PV, Hiremath SC, Patil AY, Pai SV, Handigund RS, et al. Priapism: A Rare Presentation in Chronic Myeloid Leukemia: Case Report. Urology Case Reports. 2016;4:8-10.

Musa AU, Ndakotsu MA, Abubakar SB, Agwu PN. Chronic myeloid leukemia with an initial presentation as ischemic priapism: a case report and review of literature. Arch Int Surg. 2017;7:68-72.

Ravindran M. Cauda equine compression presenting as spontaneous priapism. J Neurology Neurosurg Psychiatry. 1979;42:280-2.

Gottsch HP, Berger RE, Yang CC. Priapism: Comorbid Factors and Treatment Outcomes in a Contemporary Series. Hindawi Publishing Corporation Advances Urology. 2012;21:518-22.

Tscholl R. Priapism pathogenesis and therapy. Schweiz Med Wochenschr. 1975;105(17):517-21.

Pohl J, Pott B, Kleinhans G. Priapism: A Three-phase Concept of Management According to Aetiology and Prognosis. British J Urology. 1986;58:113-8.

Kheirandish P, Chinegwundoh F, Kulkarni S. Treating stuttering priapism. BJU Int. 2011;108:1068-72.

Raslan M, Hiew K, Hoyle A, Ross DG, Betts CD, Madidineni SB. Durgical management of stuttering ischaemic priapism: a case report and concise clinical review. Urology Case Reports. 2016;5:22-4.

Chen W, Sun SB, Sun LA, Guo JM, Wang GM. Modified technique in treating recurrent priapism: a technique report. Asian J Andrology. 2015;17:329-31

Kousournas G, Muneer A, Ralph D, Zacharakis E. Contemporary best practice in the evaluation and management of stuttering priapism. Ther Adv Urolo. 2017;9(10):227-38.

Serjeant GR, Ceulaer DK, Maude GH. Stilboestrol and Stuttering Priapism in Homozygous Sickle-Cell Disease. Lancet. 1985;2(8467):1274-6.

Yi Y, Malaeb B. Case: Temporary chemical castration in the management of recurrent priapism. Can Urol Assoc J. 2018;12(5):265-6.

Levine LA, Guss SP. Gonadotropin- releasing hormone analogues in the treatment of sickle cell anemia-associated priapism. J Urol. 1993;150:475-7.

Baker RC, Bergeson RL, Yi YA, Ward EE, Morey AF. Dutasteride in the long-term management of stuttering priapism. Transl Androl Urol. 2020;9(1):87-92.

Dahm P, Rao DS, Donatucci CF. Antiandrogens in the treatment of priapism. Urology. 2002;59:138.

Hoeh MP, Levine LA. Prevention of recurrent ischemic priapism with ketoconazole: Evolution of a treatment protocol and patient outcomes. J Sex Med. 2014;11:197-204.

Morrison B, Biurnett AL. Stuttering priapism: Insights into pathogenesis and management. Curr Urol Rep. 2012;13:268-76.

Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. feasibility of the use of phosphodiesterase-5 inhibitors in a pharmacologic prevention program for recurrent priapism. J Sex Med. 2006;3:1077-84.

Burnett AL, Anele UA, Ain T, Strouse JJ, Casella JF. Randomized controlled trial of sildenafil for preventing recurrent ischaemic priapism I sickle cell disease. Am J Med. 2014;127(7):664-8.

Gupta S, Salimpour P, De’Tejada IS, Daller M, Kraze RJ, Trash AM, et al. A possible mechanism for alteration of human erectile function by digoxin: Inhibition of corpus cavernosum Na-K ATPase activity. J Urol. 1998;159:1529-36.

Priyadarshi S. Oral terbutaline in the management of pharmacologically induced prolonged erection. Int J Impotence Res. 2004;16:424-6.

Vaidyanathan S, Watt JWH, Singh G, Hughes PL, Selmi F, Oo T, et al. Management of recurrent priapism in a cervical spinal cord injury patient with oral baclofen therapy. Spinal Cord. 2004;42:134-5.

Perimenis P, Athanosopoulos A, Barbalias G. Gabapentin in the management of recurrent refractory idiopathic priapism. Int J Impotence Res. 2004;16:84-5.